$DMRA

$21.26 +$0.17 (0.81%) Close

$DMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 61.7M shares outstanding

Who owns DMRA?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 121.8%

Hewes L. Becker 19.3% · FMR LLC 15.0%

Institutional ownership

100.0%

+9.3 pts vs last qtr

Institutional holders

100

+35 vs last qtr

Net shares bought

+8.4M

by institutions in Q2 2026

New / sold out

50 / 15

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +2.9M
Jupiter Topco LLC NEW +2.3M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −2.4M
Point72 Asset Management, L.P. −1.1M

Who is planning to sell?

Notices of proposed sale, last 12 months

$193K

1 notice from 1 person

Shares covered

7.6K

0.01% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Firmani Lori Officer $193K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+17.8%

+17.79% a year

Each share's claim on the business

−15.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $4.24M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years5% 3–5 years0% 1–3 years1% Under 1 year94%

Quarterly turnover

18.8%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting DMRA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	9.2M	14.96%	+187.5K (+2.1%)	Q4 '25	0.0%
Shares held by quarter Peak holding9.2M (Q2'26) Change over 8 quarters+9.2M Share of the company14.960% FMR LLC's full portfolio →
FF Fairmount Funds Management LLC 13D · 20.0%	8.7M	14.11%	Unchanged	Q1 '26	15.0%
Shares held by quarter Peak holding8.7M (Q1'26) Change over 8 quarters+8.7M Share of the company14.110% Disclosed stake13D · 20.0% Fairmount Funds Management LLC's full portfolio →

FMR LLC

9.2M

% of company

14.96%

Change vs last qtr

+187.5K (+2.1%)

Held since

Q4 '25

Fairmount Funds Management LLC

13D · 20.0%

8.7M

% of company

14.11%

Change vs last qtr

Unchanged

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Damora Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DMRA on Form N-PORT; together they hold 18.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FG Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust	$45.5M	1.8M	2.96%	0.05%	May 31, 2026
IR iShares Russell 2000 ETF iShares Trust	$35.3M	1.4M	2.20%	0.04%	June 30, 2026

Fidelity Growth Company Fund

Fidelity Mt. Vernon Street Trust

Position value

$45.5M

% of company

2.96%

% of the fund

0.05%

As of

May 31, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$35.3M

% of company

2.20%

% of the fund

0.04%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Damora Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
HL Hewes L. Becker Insider	11.9M	19.29%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company19.290% Hewes L. Becker's insider activity →
PE Peter Evan Harwin 5%+ holder 13D · 20.0%	8.7M	14.11%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.110% Disclosed stake13D · 20.0% View the 13D/G filing →

Hewes L. Becker

Insider

11.9M

% of company

19.29%

Change vs last qtr

—

Held since

—

Peter Evan Harwin

5%+ holder13D · 20.0%

8.7M

% of company

14.11%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Damora Therapeutics Inc.

Comments